Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Research Solutions (RSSS) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Research Solutions (RSSS) over the last 17 years, with Q3 2025 value amounting to $5.3 million.

  • Research Solutions' Operating Expenses rose 282.16% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.8 million, marking a year-over-year increase of 706.33%. This contributed to the annual value of $21.7 million for FY2025, which is 629.62% up from last year.
  • Latest data reveals that Research Solutions reported Operating Expenses of $5.3 million as of Q3 2025, which was up 282.16% from $5.1 million recorded in Q2 2025.
  • Over the past 5 years, Research Solutions' Operating Expenses peaked at $5.7 million during Q4 2024, and registered a low of $2.7 million during Q1 2021.
  • Its 5-year average for Operating Expenses is $4.3 million, with a median of $3.9 million in 2023.
  • The largest annual percentage gain for Research Solutions' Operating Expenses in the last 5 years was 6186.54% (2023), contrasted with its biggest fall of 165.01% (2023).
  • Research Solutions' Operating Expenses (Quarter) stood at $3.3 million in 2021, then increased by 12.46% to $3.7 million in 2022, then soared by 31.35% to $4.9 million in 2023, then increased by 16.81% to $5.7 million in 2024, then decreased by 8.11% to $5.3 million in 2025.
  • Its Operating Expenses was $5.3 million in Q3 2025, compared to $5.1 million in Q2 2025 and $5.7 million in Q1 2025.